Scientists hunt for a yardstick to measure rare nerve damage

NCT ID NCT07651540

First seen Jun 25, 2026 · Last updated Jul 10, 2026 · Updated 2 times

Summary

This study looks at 70 adults with sensory neuronopathy, a rare nerve condition that causes balance and coordination problems. Researchers will test several clinical scales over 12 months to see which one best tracks how the disease changes over time. The goal is to find a reliable tool for monitoring the condition and assessing future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study could identify a reliable way to measure disease progression in sensory neuronopathy, helping doctors better track the condition and evaluate treatments.
What could go wrong
This is an observational study, not a treatment trial. It may not find a clear winner among the scales, and results may not apply to all patients with sensory neuronopathy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PARANEOPLASTIC SENSORY NEURONOPATHY WITH ANTI-HU ANTIBODIES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU St Etienne

    NOT_YET_RECRUITING

    Saint-Etienne, France

  • Chu D Angers

    NOT_YET_RECRUITING

    Angers, France

  • Chu de Clermont Ferrand

    NOT_YET_RECRUITING

    Clermont-Ferrand, France

  • Chu de Grenoble

    NOT_YET_RECRUITING

    Grenoble, France

  • Chu de La Reunion

    NOT_YET_RECRUITING

    Saint-Pierre, France

  • Chu de Lille

    NOT_YET_RECRUITING

    Lille, France

  • Chu de Limoges

    NOT_YET_RECRUITING

    Limoges, France

  • Chu de Nancy

    NOT_YET_RECRUITING

    Nancy, France

  • Chu de Nantes

    NOT_YET_RECRUITING

    Nantes, France

  • Chu de Nice

    NOT_YET_RECRUITING

    Nice, France

  • Chu de Saint-Etienne

    RECRUITING

    Saint-Etienne, 42055, France

  • Chu de Toulouse

    NOT_YET_RECRUITING

    Toulouse, France

  • Chuv Centre Hospitalier Vaudois

    NOT_YET_RECRUITING

    Lausanne, Switzerland

  • Hopital de Sion

    NOT_YET_RECRUITING

    Sion, Switzerland

  • Hopital, Bicetre

    NOT_YET_RECRUITING

    Paris, France

  • Hopitaux Universitaire de Geneve

    NOT_YET_RECRUITING

    Geneva, Switzerland

  • Hopitaux Universitaire de Marseille

    NOT_YET_RECRUITING

    Marseille, France

  • Hopitaux Universitaire de Strasbourg

    NOT_YET_RECRUITING

    Strasbourg, France

  • Hospices Civils de Lyon

    NOT_YET_RECRUITING

    Lyon, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.